Abstract
The liver is the primary target of hepatitis C virus (HCV) infection. However, HCV RNA and protein are often observed to associate with B cells and other blood cells. Are these cells truly infected, and if so, does the infection lead to B cell abnormalities? Not all investigators agree. This chapter discusses our recommendations for a rigorous evaluation of the potential roles of blood cells as sites of HCV infection. The detection of HCV RNA and protein should be combined with evaluations of whether levels of these markers are sensitive to potent antiviral compounds that block HCV infection in liver cells. RNA quantitation should include documentation of sensitivity and specificity as well as a number of critical controls. Similarly, reports of protein detection should include documentation of the specificity of the antibodies used, and particularly of the frequency of antigen-positive cells relative to the number of HCV genomes detected. B cells, like other blood cells, do not express all of the cellular factors believed to be required for HCV entry or productive infection. Thus, a number of significant questions must be addressed before we understand whether, and how, infection of B cells contributes to the pathogenesis of mixed cryoglobulinemia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lanford RE, Chavez D, Chisari FV et al (1995) Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J Virol 69:8079–8083
Marukian S, Jones CT, Andrus L et al (2008) Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology 48:1843–1850
Tellinghuisen TL, Evans MJ, von Hahn T et al (2007) Studying hepatitis C virus: making the best of a bad virus. J Virol 81:8853–8867
Zehender G, Meroni L, De Maddalena C et al (1997) Detection of hepatitis C virus RNA in CD19 peripheral blood mononuclear cells of chronically infected patients. J Infect Dis 176:1209–1214
Lerat H, Rumin S, Habersetzer F et al (1998) In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood 91:3841–3849
Mellor J, Haydon G, Blair C et al (1998) Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells. J Gen Virol 79(Pt 4):705–714
Fornasieri A, Bernasconi P, Ribero ML et al (2000) Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinaemia. Clin Exp Immunol 122:400–403
Ducoulombier D, Roque-Afonso AM, Di Liberto G et al (2004) Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology 39:817–825
Baré P, Massud I, Parodi C et al (2005) Continuous release of hepatitis C virus (HCV) by peripheral blood mononuclear cells and B-lymphoblastoid cell-line cultures derived from HCV-infected patients. J Gen Virol 86:1717–1727
Pham TN, Macparland SA, Coffin CS et al (2005) Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells. J Gen Virol 86:657–666
Pal S, Sullivan DG, Kim S et al (2006) Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology 130:1107–1116
Sansonno D, Tucci FA, Lauletta G et al (2007) Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinaemia. Clin Exp Immunol 147:241–248
Pham TN, King D, Macparland SA et al (2008) Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection. Gastroenterology 134:812–822
Sung VM, Shimodaira S, Doughty AL et al (2003) Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 77:2134–2146
Pham TN, MacParland SA, Mulrooney PM et al (2004) Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 78:5867–5874
Goutagny N, Fatmi A, De Ledinghen V et al (2003) Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 187:1951–1958
Laporte J, Bain C, Maurel P et al (2003) Differential Âdistribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells. Blood 101:52–57
Rodrigue-Gervais IG, Jouan L, Beaule G et al (2007) Poly(I:C) and lipopolysaccharide innate sensing functions of circulating human myeloid dendritic cells are affected in vivo in hepatitis C virus-infected patients. J Virol 81:5537–5546
Coquillard G, Patterson BK (2009) Determination of hepatitis C virus-infected, monocyte lineage reservoirs in individuals with or without HIV coinfection. J Infect Dis 200:947–954
Boisvert J, He XS, Cheung R et al (2001) Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. J Infect Dis 184:827–835
Radkowski M, Gallegos-Orozco JF, Jablonska J et al (2005) Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41:106–114
Inokuchi M, Ito T, Uchikoshi M et al (2009) Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C. J Med Virol 81:619–627
Tuplin A, Wood J, Evans DJ et al (2002) Thermodynamic and phylogenetic prediction of RNA secondary structures in the coding region of hepatitis C virus. RNA 8:824–884
You S, Rice CM (2008) 3′ RNA elements in hepatitis C virus replication: kissing partners and long poly(U). J Virol 82:184–195
Lukavsky PJ (2009) Structure and function of HCV IRES domains. Virus Res 139:166–171
Lerat H, Berby F, Trabaud MA et al (1996) Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest 97:845–851
Gosert R, Egger D, Lohmann V et al (2003) Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons. J Virol 77:5487–5492
Rouillé Y, Helle F, Delgrange D et al (2006) Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. J Virol 80:2832–2841
Targett-Adams P, Boulant S, McLauchlan J (2008) Visualization of double-stranded RNA in cells supporting hepatitis C virus RNA replication. J Virol 82:2182–2195
Miyanari Y, Atsuzawa K, Usuda N et al (2007) The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9:1089–1097
Lindenbach BD, Evans MJ, Syder AJ et al (2005) Complete replication of hepatitis C virus in cell culture. Science 309:623–626
Heathcote EJ (2007) Antiviral therapy: chronic hepatitis C. J Viral Hepat 14(Suppl 1):82–88
Zeuzem S (2008) Interferon-based therapy for chronic Âhepatitis C: current and future perspectives. Nat Clin Pract Gastroenterol Hepatol 5:610–622
Manns MP, Foster GR, Rockstroh JK et al (2007) The way forward in HCV treatment – finding the right path. Nat Rev Drug Discov 6:991–1000
Burlone ME, Budkowska A (2009) Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. J Gen Virol 90:1055–1070
Bartosch B, Cosset FL (2006) Cell entry of hepatitis C virus. Virology 348:1–12
Brazzoli M, Bianchi A, Filippini S et al (2008) CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes. J Virol 82:8316–8329
Gottwein JM, Scheel TK, Jensen TB et al (2009) Development and characterization of hepatitis C virus genotype 1–7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 49:364–377
Evans MJ, von Hahn T, Tscherne DM et al (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446:801–805
Ploss A, Evans MJ, Gaysinskaya VA et al (2009) Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457:882–886
Stamataki Z, Shannon-Lowe C, Shaw J et al (2009) Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells. Blood 113:585–593
Zheng A, Yuan F, Li Y et al (2007) Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus. J Virol 81:12465–12471
McKeating JA, Zhang LQ, Logvinoff C et al (2004) Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81 dependent manner. J Virol 78:8496–8505
Bartosch B, Dubuisson J, Cosset F-L (2003) Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 197:633–642
Jopling CL, Yi M, Lancaster AM et al (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309:1577–1581
Randall G, Panis M, Cooper JD et al (2007) Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci USA 104:12884–12889
Chang J, Guo JT, Jiang D et al (2008) Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells. J Virol 82:8215–8223
Lanford RE, Hildebrandt-Eriksen ES, Petri A et al (2010) Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327(5962):198–201, Epub 2009 Dec 3
Jopling CL, Norman KL, Sarnow P (2006) Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122. Cold Spring Harb Symp Quant Biol 71:369–376
Syed G, Amako Y, Siddiqui A (2010) Hepatitis C virus hijacks host lipid metabolism. Trends Endocrinol Metab 21(1):33–40, Epub 2009 Oct 23
Andre P, Komurian-Pradel F, Deforges S et al (2002) Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 76:6919–6928
Nielsen SU, Bassendine MF, Burt AD et al (2006) Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J Virol 80:2418–2428
Nielsen SU, Bassendine MF, Martin C et al (2008) Characterization of hepatitis C RNA-containing particles from human liver by density and size. J Gen Virol 89:2507–2517
Gibbons GF, Wiggins D, Brown AM et al (2004) Synthesis and function of hepatic very-low-density lipoprotein. Biochem Soc Trans 32:59–64
Huang H, Sun F, Owen DM et al (2007) Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci USA 104:5848–5853
Benga WJ, Krieger SE, Dimitrova M et al (2010) Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles. Hepatology 51:43–53
Gastaminza P, Cheng G, Wieland S et al (2008) Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J Virol 82:2120–2129
Chang KS, Jiang J, Cai Z et al (2007) Human apolipoprotein E is required for infectivity and production of hepatitis C virus in cell culture. J Virol 81:13783–13793
Jiang J, Luo G (2009) Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles. J Virol 83:12680–12691
Yao H, Ye J (2008) Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells. J Biol Chem 283:849–854
Lindenbach BD, Meuleman P, Ploss A et al (2006) Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci USA 103:3805–3809
Zehender G, De Maddalena C, Bernini F et al (2005) Compartmentalization of hepatitis C virus quasispecies in blood mononuclear cells of patients with mixed cryoglobulinemic syndrome. J Virol 79:9145–9156
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Dustin, L.B., Rice, C.M. (2012). HCV and Blood Cells: How Can We Distinguish Infection from Association?. In: Dammacco, F. (eds) HCV Infection and Cryoglobulinemia. Springer, Milano. https://doi.org/10.1007/978-88-470-1705-4_6
Download citation
DOI: https://doi.org/10.1007/978-88-470-1705-4_6
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1704-7
Online ISBN: 978-88-470-1705-4
eBook Packages: MedicineMedicine (R0)